XELJANZ XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0069-0502
  • Package NDC 0069-0502-30
  • Application number NDA208246
  • SPL ID 4357a51c-e574-4cc6-96ef-9b9ee02aea1d
  • SPL set ID cf74ba2f-afc5-4baa-8594-979c889a5831
  • UNII O1FF4DIV0D
  • RxCUI 1357541
  • RxCUI 1357547
  • RxCUI 1741046
  • RxCUI 1741049
  • RxCUI 2048566
  • RxCUI 2048568
  • RxCUI 2273113
  • RxCUI 2273115
  • RxCUI 2478433
  • RxCUI 2478437

What the source publishes

Labeler
Pfizer Laboratories Div Pfizer Inc
Active ingredients
tofacitinib
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0069-0502_4357a51c-e574-4cc6-96ef-9b9ee02aea1d
{
  "name": "XELJANZ XR",
  "splId": "4357a51c-e574-4cc6-96ef-9b9ee02aea1d",
  "labels": [
    {
      "setId": "cf74ba2f-afc5-4baa-8594-979c889a5831",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf74ba2f-afc5-4baa-8594-979c889a5831"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Pfizer Laboratories Div Pfizer Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30)",
      "package_ndc": "0069-0502-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200121"
    }
  ],
  "productId": "0069-0502_4357a51c-e574-4cc6-96ef-9b9ee02aea1d",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "0069-0502",
  "deaSchedule": null,
  "genericName": "tofacitinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOFACITINIB CITRATE",
      "strength": "22 mg/1"
    }
  ],
  "applicationNumber": "NDA208246",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200121",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0300691002018",
      "0300691001011"
    ],
    "unii": [
      "O1FF4DIV0D"
    ],
    "rxcui": [
      "1357541",
      "1357547",
      "1741046",
      "1741049",
      "2048566",
      "2048568",
      "2273113",
      "2273115",
      "2478433",
      "2478437"
    ],
    "spl_set_id": [
      "cf74ba2f-afc5-4baa-8594-979c889a5831"
    ],
    "manufacturer_name": [
      "Pfizer Laboratories Div Pfizer Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0069-0502_4357a51c-e574-4cc6-96ef-9b9ee02aea1d"